JGC
IMPL

J. Goldman & Co’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

J. Goldman & Co’s Portfolio IMPL Stock Details IMPL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$63K Sell
2023
Q1 		$112K Sell
2022
Q4 		$751K Buy